• Contemporary ClinicContemporary Clinic
  • OTC GuideOTC Guide
  • Pharmacy Times
  • PTCEPTCE
  • Pharmacist Moms GroupPharmacist Moms Group
News
All News
FDA Updates
Press Releases
Media
All Videos
Digital Detail
Independent Corner
Insights
Interviews
MEDcast
Medical World News
Microsites
Peer Exchange
Perfect Consult
Podcasts
Practice Pearls
Sponsored Webcast
Student Voices
Webinars/Webcasts
Conferences
Conference Coverage
Conference Listing
Publications
Pharmacy Times
Pharmacy Practice in Focus: Oncology
Pharmacy Practice in Focus: Health Systems
Pharmacy Careers
All Publications
About the Publications
Author Submission
Submit to Pharmacy Practice in Focus: Oncology
Submit to Pharmacy Practice in Focus: Health Systems
Become a Peer Reviewer
Supplements & Featured Publications
Clinical
503B Compounding Pharmacy
ADHD
Allergy
Alzheimer Disease
Anxiety
Asthma
Atopic Dermatitis
Biosimilars
Bipolar Disorder
Brain Health
Breast Cancer
C. Difficile
COPD
COVID-19
Cardiovascular Health
Cervical Cancer
Cholangiocarcinoma
Cholesterol
Chronic Kidney Disease
Chronic Lymphocytic Leukemia
Classical Hematology
Colorectal Cancer
Continuous Glucose Monitoring
Cough and Cold
Depression
Dermatology
Diabetes
Digestive Health
Dry Eye Disease
Epilepsy
Eye Care
Flu
Future of Pharmacy
Gastrointestinal Cancer
Gastrointestinal Health
Gout
HER2 Breast Cancer
HIV
Heart Failure
Hematology
Hepatitis/MASH
Immunization
Immuno-oncology
Immunoglobulins
Infectious Disease
Lung Cancer
Lymphoma
Macular Degeneration
Mental Health
Migraine
Movement Disorders
Multiple Myeloma
Multiple Sclerosis
Myelofibrosis
Neurology
Neutropenia
Osteoporosis
Ovarian Cancer
Pain Management
Parkinson Disease
Pediatrics
Pharmacy Heroes
Pharmacy Management
Pneumococcal
PrEP
Prostate Cancer
Psoriasis
Psoriatic Arthritis
Psychedelics
Reimbursement
Reproductive Health
Respiratory Syncytial Virus
Rheumatoid Arthritis
Schizophrenia
Shingles
Skin Cancer
Sleep
Travel Vaccines
Veterinary Pharmacy
Vitamins and Supplements
Weight Management
Women's Health
Events
Upcoming Events
Upcoming Webinars
CE
Resources
Clinical Forum
Cou-Co
Educated Patient
Information for the Pharmacist
Interactive Tools
Partners
Sponsored
Whiteboards
Subscribe
logo
Spotlight
Community/RetailHospitalOncologyPharmacy TechnicianStudent
Clinical Role
Community/RetailHospitalOncologyPharmacy TechnicianSpecialty PharmacyStudent
Clinical
CoronavirusBrain HealthCardiovascular HealthDermatologyDiabetesFluHeart FailureHepatitis/MASHImmunizationMigrainePneumococcalVitamins and Supplements
Supplement Spotlight
October 2023 Pharmacy Technician Edition
All News
FDA Updates
Press Releases
All Videos
Digital Detail
Independent Corner
Insights
Interviews
MEDcast
Medical World News
Microsites
Peer Exchange
Perfect Consult
Podcasts
Practice Pearls
Sponsored Webcast
Student Voices
Webinars/Webcasts
Conference Coverage
Conference Listing
Pharmacy Times
Pharmacy Practice in Focus: Oncology
Pharmacy Practice in Focus: Health Systems
Pharmacy Careers
All Publications
About the Publications
Author Submission
Submit to Pharmacy Practice in Focus: Oncology
Submit to Pharmacy Practice in Focus: Health Systems
Become a Peer Reviewer
Supplements & Featured Publications
503B Compounding Pharmacy
ADHD
Allergy
Alzheimer Disease
Anxiety
Asthma
Atopic Dermatitis
Biosimilars
Bipolar Disorder
Brain Health
Breast Cancer
C. Difficile
COPD
COVID-19
Cardiovascular Health
Cervical Cancer
Cholangiocarcinoma
Cholesterol
Chronic Kidney Disease
Chronic Lymphocytic Leukemia
Classical Hematology
Colorectal Cancer
Continuous Glucose Monitoring
Cough and Cold
Depression
Dermatology
Diabetes
Digestive Health
Dry Eye Disease
Epilepsy
Eye Care
Flu
Future of Pharmacy
Gastrointestinal Cancer
Gastrointestinal Health
Gout
HER2 Breast Cancer
HIV
Heart Failure
Hematology
Hepatitis/MASH
Immunization
Immuno-oncology
Immunoglobulins
Infectious Disease
Lung Cancer
Lymphoma
Macular Degeneration
Mental Health
Migraine
Movement Disorders
Multiple Myeloma
Multiple Sclerosis
Myelofibrosis
Neurology
Neutropenia
Osteoporosis
Ovarian Cancer
Pain Management
Parkinson Disease
Pediatrics
Pharmacy Heroes
Pharmacy Management
Pneumococcal
PrEP
Prostate Cancer
Psoriasis
Psoriatic Arthritis
Psychedelics
Reimbursement
Reproductive Health
Respiratory Syncytial Virus
Rheumatoid Arthritis
Schizophrenia
Shingles
Skin Cancer
Sleep
Travel Vaccines
Veterinary Pharmacy
Vitamins and Supplements
Weight Management
Women's Health
Upcoming Events
Upcoming Webinars
CE
Clinical Forum
Cou-Co
Educated Patient
Information for the Pharmacist
Interactive Tools
Partners
Sponsored
Whiteboards
Subscribe
Advertisement

CLINICAL ROLE -

Community/Retail
| Hospital
| Oncology
| Pharmacy Technician
| Student

Article

March 7, 2018

Trending News Today: States Move to Lower Hemophilia Treatment Costs

Author(s):

SPT Staff

Top news of the day from across the health care landscape.

The high cost of hemophilia drugs cause many patients who are unable to afford treatment to turn to Medicaid. As a result, many states are exploring different options to manage treatment costs for the condition, according to Kaiser Health News. The hemophilia drug market, which treats approximately 20,000 patients, generates $4.6 billion a year, according to the report. One-third of these patients are covered through Medicaid, which paid approximately $353 million for the most commonly prescribed blood-clotting medication Advate, KHN noted. “We do a really aggressive job of collecting rebates on our pharmacy costs,” Jennifer Kent, director of the California Department of Health Care Services, told KHN. “But there’s just not any way around blood factor. It is just a very, very expensive product. It’s nonnegotiable for people that require it.”

On Monday, the Trump administration approved a Medicaid work requirement in Arkansas but deferred a decision on whether to roll back the state’s Medicaid expansion, which added 300,000 adults to the program, according to Kaiser Health News. Arkansas previously covered individuals with incomes less than 138% of the poverty level, but the new policy would cut the number of Medicaid-eligible people in the state by approximately 60,000. US Centers for Medicare and Medicaid Services (CMS) administrator Seema Verma recused herself from similar decisions in Indiana and Kentucky due to consulting with Medicaid agencies in those states prior to joining the Trump administration in 2017. However, the report noted she also worked with Arkansas, but still personally approved the Arkansas waiver, according to KHN. “She pledged during her confirmation to recuse herself from working on many states’ Medicaid waivers to avoid conflicts of interest, including Arkansas,” Sen. Ron Wyden (D-OR) said in a statement reported by The Hill. However, Verma said the work requirement is a positive step and “is about helping people rise out of poverty to achieve the American dream,” KHN reported.

Sen Bernie Sanders (I-VT) believes that a new health care proposal from the Center for American Progress indicates that the Democratic party is becoming more open to his “Medicare for all” platform, according to The Hill. The proposal falls short of Sanders’ single-payer plan because it still permits the option for employer-based insurance, but does provide Medicare for all people and represents a shift from previous Democratic plans, according to the report. "I believe in a Medicare for all, single-payer, but to the degree that people are talking about guaranteeing health care to all people, it's a step," Sanders told The Hill.

Related Videos
Menoapuse spelled with wooden blocks -- Image credit: loran4a | stock.adobe.com
Related Content
Advertisement
Microscopic View of Hematological Slide Showing Thrombocytopenia and Low Platelet Count in Blood
May 31st 2025

IVIG Increases Platelet Counts in Pregnant Patients With Severe Thrombocytopenia, With Identifiable Aspects of Response

Luke Halpern, Assistant Editor
Pharmacy Focus: Pharmacists' Role in Medical Cannabis Counseling and Patient Education
February 28th 2025

Pharmacy Focus: Pharmacists' Role in Medical Cannabis Counseling and Patient Education

Luke Halpern, Assistant Editor Jill Simonian, PharmD Codi Peterson, PharmD, MS
Image depicting kidney affected by CKD -- Image credit: Crystal light | stock.adobe.com
May 30th 2025

Cellular Senescence is a Central Driver of Chronic Kidney Disease-Related Kidney Fibrosis

Gillian McGovern, Associate Editor
Pharmacy Focus: World Psychedelics Day
June 14th 2024

Pharmacy Focus: World Psychedelics Day

Ashley Gallagher, Editor
Model of a kidney depicting CKD -- Image credit: kanruthai | stock.adobe.com
May 29th 2025

Childhood Cancer Survivors at an Increased Risk of Developing CKD, Study Finds

Gillian McGovern, Associate Editor
Prague, Czech Republic - August 28 2024: STELARA box with USTEKINUMAB active substance by JANSSEN, used for psoriasis, Crohn’s disease, and ulcerative colitis.
May 28th 2025

FDA Approves Ustekinumab-hmny Injection, a Biosimilar Referencing Stelara

Luke Halpern, Assistant Editor
Related Content
Advertisement
Microscopic View of Hematological Slide Showing Thrombocytopenia and Low Platelet Count in Blood
May 31st 2025

IVIG Increases Platelet Counts in Pregnant Patients With Severe Thrombocytopenia, With Identifiable Aspects of Response

Luke Halpern, Assistant Editor
Pharmacy Focus: Pharmacists' Role in Medical Cannabis Counseling and Patient Education
February 28th 2025

Pharmacy Focus: Pharmacists' Role in Medical Cannabis Counseling and Patient Education

Luke Halpern, Assistant Editor Jill Simonian, PharmD Codi Peterson, PharmD, MS
Image depicting kidney affected by CKD -- Image credit: Crystal light | stock.adobe.com
May 30th 2025

Cellular Senescence is a Central Driver of Chronic Kidney Disease-Related Kidney Fibrosis

Gillian McGovern, Associate Editor
Pharmacy Focus: World Psychedelics Day
June 14th 2024

Pharmacy Focus: World Psychedelics Day

Ashley Gallagher, Editor
Model of a kidney depicting CKD -- Image credit: kanruthai | stock.adobe.com
May 29th 2025

Childhood Cancer Survivors at an Increased Risk of Developing CKD, Study Finds

Gillian McGovern, Associate Editor
Prague, Czech Republic - August 28 2024: STELARA box with USTEKINUMAB active substance by JANSSEN, used for psoriasis, Crohn’s disease, and ulcerative colitis.
May 28th 2025

FDA Approves Ustekinumab-hmny Injection, a Biosimilar Referencing Stelara

Luke Halpern, Assistant Editor
Consent Preferences
About Us
Clinical Forums
Advertise
Contact Us
Editorial Staff
Privacy Policy
Terms & Conditions
Do Not Sell My Information
Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences

All rights reserved.